Atrial functional mitral regurgitation — the recently defined pathophysiological entity of significant mitral regurgitation developing in patients with long-standing atrial fibrillation and atrial dilation in the absence of intrinsic leaflet disease or left ventricular dysfunction, caused by mitral annular dilation and posterior leaflet flattening from atrial enlargement — creating a growing indication for mitral valve repair within the Annuloplasty Rings Market, with prevalence increasing as the global atrial fibrillation epidemic generates a larger population of patients with AF-associated mitral annular dilation and significant MR.

Atrial MR pathophysiology — the annuloplasty ring rationale — the progressive left atrial and mitral annular dilation accompanying chronic atrial fibrillation — extending predominantly the posterior annular segment (where the flexible posterior annulus is anchored to the atrial wall rather than the fibrous skeleton) — increasing the anterior-posterior mitral annular diameter and flattening the posterior mitral leaflet angle, reducing leaflet coaptation surface and creating MR even with structurally normal leaflets. Pure annular remodeling by a partial posterior annuloplasty band (addressing the posterior annular dilation without constraining the fibrous anterior annulus) representing the theoretically optimal repair for atrial MR where the pathology is confined to posterior annular dilation.

Clinical recognition and treatment guideline evolution — the atrial MR emerging indication — the 2021 ACC/AHA Valvular Heart Disease guideline explicitly recognizing atrial functional MR as a distinct clinical entity from ventricular functional MR, with different pathophysiology, natural history, and potentially different treatment approach. The guideline acknowledging that restoration of sinus rhythm (through catheter ablation) combined with optimal rate control may reduce atrial MR severity by reducing atrial and annular dilation — creating the question of whether AF ablation plus observation is preferable to or complementary with surgical annuloplasty for atrial MR management. Concomitant maze procedure for AF combined with posterior band annuloplasty for mitral MR represents the combined surgical approach addressing both the rhythm and structural components of atrial MR.

Atrial MR versus ventricular functional MR — the differential diagnosis importance — the clinical distinction between atrial functional MR (normal or hyperdynamic LV function, large LA, chronic AF, normal LV size, posterior leaflet flattening without tethering, responds well to annuloplasty) and ventricular functional MR (dilated cardiomyopathy, LV dysfunction, normal or dilated LA, leaflet tethering, less responsive to annuloplasty alone) critical for appropriate surgical decision-making and ring selection. Echocardiographic parameters distinguishing atrial MR (LVEF normal, LV volumes normal, isolated posterior annular dilation, no leaflet tethering, AF present) from ventricular MR (LV dilation, reduced LVEF, leaflet tethering, coaptation depth increased) guiding the surgical approach and expected repair durability.

Do you think catheter ablation of atrial fibrillation combined with cardiac remodeling will replace surgical annuloplasty as the primary treatment for atrial functional MR in most patients, or will the persistence of annular dilation after AF ablation in many patients require surgical annuloplasty as the definitive treatment for established atrial MR?

FAQ

How is atrial functional MR diagnosed and distinguished from other causes of mitral regurgitation? Atrial functional MR diagnostic criteria: diagnostic features: moderate to severe MR by comprehensive echocardiographic assessment; persistent or longstanding atrial fibrillation (typically >years duration); significantly dilated left atrium (LAVi >40 mL/m2); normal or preserved LVEF (>50%); normal LV dimensions (LVESD <40mm); posterior mitral leaflet specific changes: posterior leaflet flattening; increased posterior annular diameter; reduced posterior leaflet angulation (<120°); absence of intrinsic leaflet disease (no prolapse, flail, rheumatic thickening, vegetation); absence of ventricular functional MR features: no significant LV dilation; no leaflet tethering (coaptation depth normal, tenting area normal); echocardiographic parameters: posterior annular diameter >35mm (in absence of LV dilation); lateral annular diameter increased disproportionate to septal annulus; posterior leaflet lateral angle (normal: >140°; atrial MR: <120°); MR mechanism: posteriorly directed jet typical (posterior leaflet restricted); central jet if symmetric annular dilation; color Doppler assessment; quantification: PISA EROA; volumetric method; vena contracta; clinical context: AF burden (persistent, longstanding persistent, permanent); prior AF ablation history; concomitant tricuspid regurgitation (atrial functional TR often coexisting); confounders: combined atrial and ventricular MR — common; careful assessment of LV function and volume; distinguishing primary from secondary MR components; treatment implications: medical: rate control, GDMT, diuretics; rhythm: AF ablation — may reduce atrial MR if LA remodeling achieved; surgical: posterior annuloplasty band for atrial MR — addressing posterior annular dilation; combined maze procedure for AF; transcatheter: MitraClip in high-risk atrial MR patients — limited data; emerging indication.

What are the outcomes of surgical annuloplasty specifically for atrial functional MR? Atrial functional MR surgical outcomes: limited but growing evidence: distinguishing atrial MR from ventricular MR in published series only recently standardized; historical series often mixed populations; specific atrial MR data: Takahashi et al. (JTCVS 2020): forty-seven patients with AF-related atrial MR; partial posterior band repair; freedom from significant MR recurrence at three years: eighty-four percent; improved LA size and LVEF post-repair; Han et al. (JTCVS 2021): concomitant maze + posterior band versus maze alone; lower MR recurrence with combined procedure at one year; comparative data: atrial MR repair outcomes generally superior to ventricular ischemic MR repair; less leaflet tethering pathology; MR mechanism more addressable by annular remodeling alone; ring versus band: posterior partial band (Edwards MC3, Medtronic Duran posterior) theoretically optimal for posterior annular dilation; complete ring also used; no RCT comparing band versus ring for atrial MR; LA remodeling post-repair: surgical repair associated with LA reverse remodeling (LA size reduction) at one year; rhythm: sinus rhythm restoration facilitating atrial reverse remodeling post-repair; maze procedure improving long-term sinus rhythm maintenance; remaining questions: optimal ring/band type for atrial MR; role of AF ablation timing relative to repair; whether medical management alone (rate control + diuretics) sufficient for mild-moderate atrial MR; prospective registry data developing.

#AtrialFunctionalMR #AnnuloplastyRingsMarket #AtrialFibrillation #MitralValveRepair #AtrialMR